Matthew Jones, OD
Optometrist · Blytheville, ARNPI 1144468679
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.6%), speaking fees and entertainment — rather than concentrated in one kind of arrangement. Lumenis BE Inc accounts for 62.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $1,315 and has fallen 65.8% since, to $450 in 2025. Among optometrist clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $81.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$2K
- Biotissue Holdings Inc.$165
- Glaukos Corporation$127
- Johnson & Johnson Vision Care, Inc.$116
- Optos, Inc.$97
- Alcon$94
- plus $397 from 9 others
What the payments were for
- Speaking & faculty fees$1,22547%
- Food & beverage$1,29950%
- Entertainment$974%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 3 | $1,625 |
| Biotissue Holdings Inc. | 5 | $165 |
| Glaukos Corporation | 1 | $127 |
| Johnson & Johnson Vision Care, Inc. | 6 | $116 |
| Optos, Inc. | 1 | $97 |
| Alcon | 4 | $94 |
| Sight Sciences, Inc. | 1 | $89 |
| Coopervision Inc. | 2 | $72 |
| Shire North American Group Inc | 1 | $66 |
| Rxsight Inc | 1 | $50 |
| Maculogix, Inc. | 2 | $39 |
| Bausch & Lomb Americas Inc. | 2 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| AbbVie | 1 | $17 |
| ABB Con-cise Optical Group LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- optilight$1,425
- M22$200
- iStent Infinite$127
- iDoseTR$127
- Photrexa Viscous and Photrexa$127
How this compares
$2,621 in reported general payments places this provider in the 90th percentile of 442 optometrist providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 61 | $24,049 |
| RestasisCyclosporine | 14 | $11,564 |
| CombiganBrimonidine Tartrate/Timolol | 31 | $10,013 |
| Prednisolone Acetate | 172 | $8,117 |
| Brimonidine Tartrate | 72 | $3,891 |
| Latanoprost | 338 | $2,860 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 12 | $2,551 |
| Azelastine Hcl | 61 | $1,756 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 32 | $448 |
| Timolol Maleate | 45 | $335 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan | $17 | $45,626106 claims |
| AlconSimbrinza | $94 | $2,55112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 442 optometrist providers in Arkansas.
Other optometrist in Blytheville
- Jennifer ButtonBlytheville$3K
- Christen CoatsFayetteville$216K
- Christopher MorrisRogers$6K
- Russell SimmonsBenton$6K
- Andrea HorneTontitown$6K
- Shelby BrogdonLittle Rock$5K
- Ryan BunchRogers$5K
- Alex BellRogers$5K
- Melissa PolkEl Dorado$5K
- Kristin LawSherwood$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.